ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,918Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 68

$578K Total Retail Price of All Prescriptions

Rank: 14 out of 68

360 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

20% of this provider’s 360 patients filled at least one prescription for a schedule two drug, compared to an average of 11%.

Schedule Three
Controlled Substances

3% of this provider’s 360 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 10,313 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 29.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
FUROSEMIDE 549 496 1 3
SIMVASTATIN 510 435 2 1
AMLODIPINE BESYLATE 466 403 3 7
LISINOPRIL 440 397 4 4
METOPROLOL TARTRATE 320 307 5 6
OMEPRAZOLE 302 231 6 5
WARFARIN SODIUM 276 247 7 8
LEVOTHYROXINE SODIUM 272 212 8 2
GABAPENTIN 215 176 9 12
DONEPEZIL HCL 208 200 10 10
HYDROCHLOROTHIAZIDE 198 181 11 11
MIRTAZAPINE 197 185 12 15
LIDODERM 196 191 13 68
LANTUS 150 131 14 36
METFORMIN HCL 141 126 15 14
METOPROLOL SUCCINATE 141 119 15 19
SANTYL 128 116 17 87
ATORVASTATIN CALCIUM 127 119 18 13
OXYCONTIN 125 97 S2 19 92
CARVEDILOL 123 117 20 27
RISPERIDONE 122 103 21 25
TRAMADOL HCL 117 114 22 23
NAMENDA 117 116 22 16
RANITIDINE HCL 116 104 24 34
FAMOTIDINE 116 103 24 56
CITALOPRAM HBR 111 107 26 9
POTASSIUM CHLORIDE 109 105 27 18
ATENOLOL 105 105 28 21
SERTRALINE HCL 105 104 28 20
NOVOLOG MIX 70-30 95 82 30 235
OXYCODONE HCL 90 54 S2 31 75
LEVETIRACETAM 86 57 32 44
NYSTOP 85 81 33 106
ADVAIR DISKUS 84 57 34 41
ISOSORBIDE MONONITRATE ER 84 84 34 35
ALENDRONATE SODIUM 81 81 36 26
DIOVAN 78 61 37 42
LATANOPROST 77 75 38 63
NYSTATIN 76 72 39 74
CLOPIDOGREL 76 64 39 31
ENALAPRIL MALEATE 68 67 41 61
HYDRALAZINE HCL 64 54 42 51
ESCITALOPRAM OXALATE 63 48 43 38
PANTOPRAZOLE SODIUM 62 50 44 30
TAMSULOSIN HCL 61 59 45 28
NOVOLOG 60 57 46 78
OXYCODONE-ACETAMINOPHEN 59 19 S2 47 43
CIPROFLOXACIN HCL 57 51 48 55
LACTULOSE 56 33 49 127
SULFAMETHOXAZOLE-TRIMETHOPRIM 54 50 50 80
LOVASTATIN 53 40 51 76
FLUTICASONE PROPIONATE 53 47 51 66
POLYETHYLENE GLYCOL 3350 52 50 53 22
BACLOFEN 52 39 53 82
KLOR-CON M20 51 51 55 40
GLIPIZIDE 50 50 56 54
DIVALPROEX SODIUM 50 47 56 49
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 8, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.